KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pfizer (PFE) Income from Continuing Operations (2016 - 2025)

Pfizer (PFE) has disclosed Income from Continuing Operations for 17 consecutive years, with 1640000000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations changed N/A to 1640000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7787000000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at 7786000000.0 for FY2025, 3.29% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 1640000000.0 at Pfizer, down from 3550000000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 9877000000.0 in Q3 2022, with the low at 3349000000.0 in Q4 2023.
  • Average Income from Continuing Operations over 5 years is 3698000000.0, with a median of 3550000000.0 recorded in 2025.
  • The sharpest move saw Income from Continuing Operations plummeted 127.62% in 2023, then skyrocketed 9264.52% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 8171000000.0 in 2021, then increased by 5.8% to 8645000000.0 in 2022, then crashed by 138.74% to 3349000000.0 in 2023, then skyrocketed by 233.8% to 4481000000.0 in 2024, then tumbled by 136.6% to 1640000000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 1640000000.0, 3550000000.0, and 2903000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.